Published in Oncotarget on November 09, 2016
The Pleiotropic Role of L1CAM in Tumor Vasculature. Int J Mol Sci (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics (2000) 19.26
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials (2007) 14.51
L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet (2003) 1.67
L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr (2012) 1.52
Melanoma-specific marker expression in skin biopsy tissues as a tool to facilitate melanoma diagnosis. J Invest Dermatol (2010) 1.52
L1, β-catenin, and E-cadherin expression in patients with colorectal cancer: correlation with clinicopathologic features and its prognostic significance. J Surg Oncol (2010) 1.50
Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res (2007) 1.46
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation. J Natl Cancer Inst (2013) 1.40
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene (2006) 1.27
L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol (2006) 1.25
L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Clin Cancer Res (2012) 1.24
Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation. Ann Oncol (2012) 1.21
L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Ann Surg Oncol (2007) 1.20
Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J Pathol (2010) 1.20
The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res (2005) 1.19
The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol (2012) 1.15
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res (2008) 1.14
Role of L1 in neural development: what the knockouts tell us. Mol Cell Neurosci (1998) 1.12
L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol (2007) 1.10
L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results. Eur J Cancer (2014) 1.07
L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Diagn Pathol (2012) 1.07
Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol (2010) 1.05
L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions. BMC Mol Biol (2010) 1.03
Expression and prognostic value of L1-CAM in breast cancer. Oncol Rep (2009) 1.00
L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer. J Hematol Oncol (2013) 0.99
Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion. J Clin Pathol (2005) 0.98
L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol Cancer (2011) 0.98
L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells. Carcinogenesis (2010) 0.98
L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. Clin Cancer Res (2009) 0.96
L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients. J Exp Clin Cancer Res (2013) 0.95
DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer. Int J Oncol (2009) 0.95
The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor. Int J Biochem Cell Biol (2009) 0.95
L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma. J Surg Oncol (2011) 0.94
L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma. Hum Pathol (2011) 0.94
L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA). Gynecol Oncol (2016) 0.90
Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer. Ann Surg Oncol (2013) 0.90
Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma. Oncol Rep (2010) 0.90
L1 (CAM) (CD171) in ovarian serous neoplasms. Eur J Gynaecol Oncol (2008) 0.89
Expression of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancer. Anticancer Res (2009) 0.88
L1 (CD171) is highly expressed in gastrointestinal stromal tumors. Mod Pathol (2006) 0.88
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer. Mod Pathol (2016) 0.86
L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors. Ann Surg Oncol (2007) 0.84
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor. BMC Cancer (2014) 0.84
L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma. Pathol Oncol Res (2016) 0.83
Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients. BMC Cancer (2011) 0.82
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study. Br J Cancer (2016) 0.81
L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors. APMIS (2009) 0.80
Expression of L1 protein correlates with cluster of differentiation 24 and integrin β1 expression in gastrointestinal stromal tumors. Oncol Lett (2015) 0.78
Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer. Oncotarget (2016) 0.78
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study. BMC Cancer (2016) 0.76
Evaluating L1CAM expression in human endometrial cancer using qRT-PCR. Oncotarget (2016) 0.76
Glycoconjugate expression in adenoid cystic carcinoma of the salivary glands: up-regulation of L1 predicts fatal prognosis. Histopathology (2011) 0.76
Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas. Oncotarget (2016) 0.76